Results 121 to 130 of about 6,545 (188)
XC Motif Chemokine Ligand 1 (XCL1, known as lymphotactin), acting via XCR1, is a member of the chemokine family which includes molecules with chemotactic functions. However, subsequent years of research on this chemokine, while simultaneously exploring and understanding the complexity of the processes taking place in living organisms, have revealed a ...
Agata, Ciechanowska, Joanna, Mika
openaire +2 more sources
Recent studies have uncovered evidences for pro-tumorigenic activities attributed to IL-11, prompting a renewed focus on therapeutic strategies targeting IL-11 signaling for anti-tumor treatment. Here, we introduce 9MW3811, a monoclonal antibody designed
Chang Zhang +8 more
doaj +1 more source
Childhood Sjögren’s disease represents critically unmet medical needs due to a complete lack of immunological and molecular characterizations. This study presents key immune cell subsets and their interactions in the periphery in childhood Sjögren’s ...
Myung-Chul Kim +11 more
doaj +1 more source
The Role of Chemokines in Obesity and Exercise-Induced Weight Loss
Obesity is a global health crisis that is closely interrelated to many chronic diseases, such as cardiovascular disease and diabetes. This review provides an in-depth analysis of specific chemokines involved in the development of obesity, including C-C ...
Wenbi He +4 more
doaj +1 more source
Progress in research on C-chemokine XCL1
Lei Yu, Gui-Bo Yang
openaire +1 more source
Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis. [PDF]
Zhao X +16 more
europepmc +1 more source
Evaluation of Immunoprotective Effects of DNA Vaccine Based on <i>Eimeria maxima</i> EF-1α Antigen and Chicken XCL1 Chemokine. [PDF]
Lin XF +9 more
europepmc +1 more source
Expression von Lymphotaktin (XCL1) bei der Wegener'schen Granulomatose [PDF]
openaire +1 more source
Single-cell dissection of hepatocellular carcinoma immunity: from heterogeneous subtypes to precision therapeutics. [PDF]
Liang Y +6 more
europepmc +1 more source

